JPS55111418A - Remedy for eye disease and its preparation - Google Patents

Remedy for eye disease and its preparation

Info

Publication number
JPS55111418A
JPS55111418A JP1995779A JP1995779A JPS55111418A JP S55111418 A JPS55111418 A JP S55111418A JP 1995779 A JP1995779 A JP 1995779A JP 1995779 A JP1995779 A JP 1995779A JP S55111418 A JPS55111418 A JP S55111418A
Authority
JP
Japan
Prior art keywords
remedy
formula
eye disease
compound
major component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1995779A
Other languages
Japanese (ja)
Other versions
JPS6360727B2 (en
Inventor
Junichi Iwao
Masayuki Ooya
Takehisa Chiba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP1995779A priority Critical patent/JPS55111418A/en
Publication of JPS55111418A publication Critical patent/JPS55111418A/en
Publication of JPS6360727B2 publication Critical patent/JPS6360727B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: A remedy for treating eye disease such as pigmentary degeneration that contains cyanidine chloride as the major component.
CONSTITUTION: Said remedy contains cyanidine chloride, the compound of formula I, which occurs in plants, or its salt, as the major component. It is used to treat pigmentary degeneration, dark adaptation maladjustment or diabetic cataract. The compound of formula I is obtained by reductive deacylation of quercetin pentacarboxylate of formula II with a metal hydride complex of formula III (M is alkali metal; R is lower alkyl, lower alkoxyalkyl; n is 1, 2) followed by treatment with hydrochloric acid.
COPYRIGHT: (C)1980,JPO&Japio
JP1995779A 1979-02-21 1979-02-21 Remedy for eye disease and its preparation Granted JPS55111418A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1995779A JPS55111418A (en) 1979-02-21 1979-02-21 Remedy for eye disease and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1995779A JPS55111418A (en) 1979-02-21 1979-02-21 Remedy for eye disease and its preparation

Publications (2)

Publication Number Publication Date
JPS55111418A true JPS55111418A (en) 1980-08-28
JPS6360727B2 JPS6360727B2 (en) 1988-11-25

Family

ID=12013667

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1995779A Granted JPS55111418A (en) 1979-02-21 1979-02-21 Remedy for eye disease and its preparation

Country Status (1)

Country Link
JP (1) JPS55111418A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410749A2 (en) * 1989-07-28 1991-01-30 IDB HOLDING S.p.A. Anthocyanidins for the treatment of ophthalmic diseases
EP0490615A1 (en) * 1990-12-10 1992-06-17 IDB HOLDING S.p.A. Process for synthesising anthocyanidins
US5643932A (en) * 1990-11-30 1997-07-01 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
US8198249B2 (en) * 2004-07-29 2012-06-12 Board Of Trustees Of Michigan State University Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
US8354439B2 (en) 1996-09-30 2013-01-15 Otsuka Pharmaceutical Co., Ltd. Agent for inhibition of cytokine production and agent for inhibition of cell adhesion

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410749A2 (en) * 1989-07-28 1991-01-30 IDB HOLDING S.p.A. Anthocyanidins for the treatment of ophthalmic diseases
US5643932A (en) * 1990-11-30 1997-07-01 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
US5677319A (en) * 1990-11-30 1997-10-14 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
US6080764A (en) * 1990-11-30 2000-06-27 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
USRE37556E1 (en) 1990-11-30 2002-02-19 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
EP0490615A1 (en) * 1990-12-10 1992-06-17 IDB HOLDING S.p.A. Process for synthesising anthocyanidins
US8354439B2 (en) 1996-09-30 2013-01-15 Otsuka Pharmaceutical Co., Ltd. Agent for inhibition of cytokine production and agent for inhibition of cell adhesion
US8198249B2 (en) * 2004-07-29 2012-06-12 Board Of Trustees Of Michigan State University Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia

Also Published As

Publication number Publication date
JPS6360727B2 (en) 1988-11-25

Similar Documents

Publication Publication Date Title
GR3017996T3 (en) 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
JPS55111418A (en) Remedy for eye disease and its preparation
ES8706654A1 (en) Benzothiazine derivatives.
NZ208691A (en) Dihydrodibenzocycloheptylidene-ethylpiperazine derivatives and pharmaceutical compositions thereof
EP0348527A4 (en) Antiallergic eye drop
JPS5489036A (en) Remedy and preventive for hypersensitivity to light
DE3277971D1 (en) Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use
PT75818A (en) Process for the preparation of cycloalkyl-(alpha-triazolyl-beta-hydroxy)-ketones with fungicidal and plant growth regulators effect
RU94046058A (en) Agent for cataract treatment and prophylaxis, method of its synthesis, use of (+)-(2s,3s)-3-[(s)-3-methyl-1-(3-methylbutylcarbamoyl)-butylca- -rbamoyl]-2-oxyrancarboxylic acid, its salt and ethyl ester for preparing agent, method of cataract treatment and prophylaxis, method of an aqueous solution preparing
JPS533519A (en) Preventives for viral blight of plant
JPS56121436A (en) Formula stock feed
US3284296A (en) Trialkyl tin compounds as molluscicides
US3660570A (en) Treatment for heart worm microfilariae
DE2231890A1 (en) METHOD OF PROTECTING SEED FROM FUNGAL INFECTION
JPS55102516A (en) Remedy for glaucoma
JPS5780321A (en) Cardiotonic agent
NO980357L (en) Polyhydroksyalkylamidbetainer
JPS52110885A (en) Consistent cultivation of algae
US2261188A (en) Stabilized form of vitamin b6 and process of preparing the same
JPS5738705A (en) Herbicide for rice paddy
RU2002109177A (en) The method of regulating the growth and development of crops
BG50652A1 (en) Metal coordination compounds of n- benzyl- n'- 2- pyridyl- thiocarbamide and method for their preparation
JPS55108853A (en) Bis(3-ethoxycarbonyl-4,6-dimethyl-2-pyridylthio)zinc and its preparation
SU1739941A1 (en) Fungicidal composition for treatment of potato plants
Myers et al. Controlling Taste and Odor with Chlorine Dioxide